A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFRVIII-mutated glioblastoma cells via macrophages
Abstract Background Autologous chimeric antigen receptor (CAR) expressing T-Cells (CAR-T) have been efficiently used in hematological malignancies but their efficacy in solid tumors remains limited. CAR therapies via the use of macrophages, offer a promising avenue due to their unique ability to inf...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2026-05-01
|
| Серія: | BMC Cancer |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12885-026-16080-5 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|